CTRI/2009/091/000460已完成3 期
A Multinational, Multicenter, Randomized, Double-Blind study Comparing the Efficacy and Safety of AVE5026 with enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Hip Fracture Surgery (SAVE HIP 2)
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Standard surgery for fracture of the upper third of the femur including femoral head and neck.
排除标准
- •- Estimated time of injury/fracture > 24 hours before admission to hospital
- •- Any major orthopedic surgery in the 3 months prior to study start
- •- Multiple trauma affecting more than one organ system
- •- Deep vein thrombosis or pulmonary embolism within the last 12 months or known post-phlebitic syndrome
- •- Patients at high risk of bleeding
- •- Known allergy to heparin, or enoxaparin, or pork products
研究者
相似试验
进行中（未招募）
不适用
A Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Tolerability and Safety of talampanel in Subjects with Amyotrophic Lateral Sclerosis (ALS).ALS-TAL-201-OL is added as an open label extension of the ALS-TAL-201 trial: A Multinational, Multicenter, Open label phase to Assess Tolerability and Safety of Talampanel 50mg tid in Subjects with Amyotrophic Lateral Sclerosis (ALS).EUCTR2008-002062-62-BETeva Pharmaceutical Industries, Ltd540
已完成
不适用
A Multinational, Multicenter, Randomized, Double-Blind study Comparing the Efficacy and Safety of AVE5026 with placebo for the Extended Prevention of Venous Thromboembolism in Patients Having Undergone Hip Fracture Surgery - SAVE-HIP3-I82I82PER-079-08sanofi-aventis Recherche & Development,
进行中（未招募）
不适用
A Multinational, Multicenter, Randomized, Double-Blind study Comparing the Efficacy and Safety of AVE5026 with enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Hip Fracture Surgery - SAVE-HIP2The subjects who will participate to this clinical trial are patients undergoing Hip Fracture Surgery.MedDRA version: 9.1Level: LLTClassification code 10049909Term: Venous thromboembolism prophylaxisEUCTR2007-007945-11-PTsanofi-aventis recherche & développement1,000
进行中（未招募）
不适用
A Multinational, Multicenter, Randomized, Double-Blind study Comparing the Efficacy and Safety of AVE5026 with enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Hip Fracture Surgery - SAVE-HIP2The subjects who will participate to this clinical trial are patients undergoing Hip Fracture Surgery.MedDRA version: 9.1Level: LLTClassification code 10049909Term: Venous thromboembolism prophylaxisEUCTR2007-007945-11-BGsanofi-aventis recherche & développement1,000
已完成
不适用
A Multinational, Multicenter, Randomized, Double-Blind study Comparing the Efficacy and Safety of AVE5026 with enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Hip Fracture Surgery - SAVE-HIP2PER-080-08sanofi-aventis Recherche & Development,